| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/6/2023 | $29.00 | Neutral | UBS |
| 11/13/2023 | $30.00 | Neutral → Buy | BofA Securities |
| 5/9/2023 | $25.00 → $27.00 | Underperform → Neutral | BofA Securities |
| 2/8/2023 | $25.00 → $26.50 | Mkt Perform → Outperform | Keefe Bruyette |
| 1/9/2023 | $24.50 | Neutral → Underperform | Credit Suisse |
| 9/6/2022 | $27.00 | Overweight → Neutral | JP Morgan |
| 8/18/2022 | $25.00 | Neutral → Underperform | BofA Securities |
| 7/18/2022 | $28.00 → $27.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 10/12/2021 | $24.00 | Buy | Citigroup |
| 10/11/2021 | $23.00 | Neutral | BofA Securities |
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G - Enact Holdings, Inc. (0001823529) (Subject)
Strategic Highlights Expanded the CareScout Quality Network to all 50 states, covering over 86% of the aged 65-plus census population in the United States Continued progress on the LTC1 multi-year rate action plan with $40M of gross incremental premium approvals; approximately $31.2B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Executed $51M in share repurchases in the quarter at an average price of $7.32 per share; $186M executed in 2024 at an average price of $6.52 per share; $565M in share repurchases program-to-date through February 14th at an average price of $5.69 per share Repurchased $31M in principal of holding company debt at a discount
GAAP Net Income of $163 million, or $1.05 per diluted shareAdjusted Operating Income of $169 million, or $1.09 per diluted shareReturn on Equity of 13.0% and Adjusted Operating Return on Equity of 13.5%Record Primary insurance in-force of $269 billion, a 2% increase from fourth quarter 2023PMIERs Sufficiency of 167% or $2,052 millionBook Value Per Share of $32.80 and Book Value Per Share excluding AOCI of $34.16Returned over $350 million of capital to shareholders in 2024Announces quarterly cash dividend of $0.185 per common share RALEIGH, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced its fourth quarter and full-year 2024 results.
RALEIGH, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its flagship legal entity, Enact Mortgage Insurance Corporation, has secured approximately $225 million and $260 million of additional excess of loss (XOL) reinsurance coverage. These credit risk transfer (CRT) transactions cover a portion of expected new insurance written for the 2025 book year (policies written from January 1, 2025 through December 31, 2025) and 2026 book year (policies written from January 1, 2026 through December 31, 2026) respectively, and are effective January 1, 2025 and
RALEIGH, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that Fitch Ratings ("Fitch") upgraded the insurance financial strength rating for our flagship insurance subsidiary, Enact Mortgage Insurance Corporation, to A from A-. Fitch also upgraded Enact's senior debt rating to BBB from BBB-. The outlook for both ratings is stable. "The upgrades from Fitch reflect the progress we've made in strengthening our financial foundation and delivering on our strategic priorities, while continuing to effectively manage our risk and operate from a position of financia
RALEIGH, N.C., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 4, 2025. Enact will host a conference call to review fourth quarter 2024 financial results on February 5, 2025 at 8:00 a.m. (ET). Enact's earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com/, at the time of their release to the public. Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to
Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing fourth quarter results after the market closes on February 18, 2025. A conference call will be held on February 19, 2025, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's February 19 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #5461958. To participat
RALEIGH, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its flagship legal entity, Enact Mortgage Insurance Corporation, has entered into two quota share reinsurance agreements with a broad panel of highly-rated reinsurers. Under the agreements, and subject to certain conditions, Enact will cede approximately 27% of a portion of expected new insurance written for the period from January 1, 2025 through December 31, 2025 and will cede approximately 27% of a portion of expected new insurance written for the period from January 1, 2026 through December
Strategic Highlights Continued progress on the LTC1 multi-year rate action plan (MYRAP) with $124M of gross incremental premium approvals; approximately $30B estimated net present value achieved from in-force rate actions (IFAs) since 2012 Expanded the CareScout Quality Network to 49 states through October, covering over 75% of the aged 65-plus Census population in the United States; on track to achieve 80% to 85% coverage by year-end Executed $36M in share repurchases in the quarter; $144M executed year-to-date through October at an average price of $6.29 per share Repurchased $17M in principal of holding company debt at a discount Financial Highlights Net income2 of $85M, or $
GAAP Net Income of $181 million, or $1.15 per diluted shareAdjusted Operating Income of $182 million, or $1.16 per diluted shareReturn on Equity of 14.7% and Adjusted Operating Return on Equity of 14.8%Record Primary insurance in-force of $268 billion, a 2% increase from third quarter 2023PMIERs Sufficiency of 173% or $2,190 millionBook Value Per Share of $32.61 and Book Value Per Share excluding AOCI of $33.27Announces quarterly cash dividend of $0.185 per common share RALEIGH, N.C., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the third quarter of 2024. "Our strong third-quarter performance underscores the continued successfu
Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing third quarter results after the market closes on November 6, 2024. A conference call will be held on November 7, 2024, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's November 7 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #1689846. To participate in t
8-K - Enact Holdings, Inc. (0001823529) (Filer)
SCHEDULE 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
10-Q - Enact Holdings, Inc. (0001823529) (Filer)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
10-Q - Enact Holdings, Inc. (0001823529) (Filer)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
424B5 - Enact Holdings, Inc. (0001823529) (Filer)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00
BofA Securities upgraded Enact Holdings from Neutral to Buy and set a new price target of $30.00
BofA Securities upgraded Enact Holdings from Underperform to Neutral and set a new price target of $27.00 from $25.00 previously
Keefe Bruyette upgraded Enact Holdings from Mkt Perform to Outperform and set a new price target of $26.50 from $25.00 previously
Credit Suisse downgraded Enact Holdings from Neutral to Underperform and set a new price target of $24.50
JP Morgan downgraded Enact Holdings from Overweight to Neutral and set a new price target of $27.00
BofA Securities downgraded Enact Holdings from Neutral to Underperform and set a new price target of $25.00
Keefe Bruyette downgraded Enact Holdings from Outperform to Mkt Perform and set a new price target of $27.00 from $28.00 previously
Citigroup initiated coverage of Enact Holdings with a rating of Buy and set a new price target of $24.00
BofA Securities initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $23.00
Strategic Highlights Expanded the CareScout Quality Network to all 50 states, covering over 86% of the aged 65-plus census population in the United States Continued progress on the LTC1 multi-year rate action plan with $40M of gross incremental premium approvals; approximately $31.2B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Executed $51M in share repurchases in the quarter at an average price of $7.32 per share; $186M executed in 2024 at an average price of $6.52 per share; $565M in share repurchases program-to-date through February 14th at an average price of $5.69 per share Repurchased $31M in principal of holding company debt at a discount
GAAP Net Income of $163 million, or $1.05 per diluted shareAdjusted Operating Income of $169 million, or $1.09 per diluted shareReturn on Equity of 13.0% and Adjusted Operating Return on Equity of 13.5%Record Primary insurance in-force of $269 billion, a 2% increase from fourth quarter 2023PMIERs Sufficiency of 167% or $2,052 millionBook Value Per Share of $32.80 and Book Value Per Share excluding AOCI of $34.16Returned over $350 million of capital to shareholders in 2024Announces quarterly cash dividend of $0.185 per common share RALEIGH, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced its fourth quarter and full-year 2024 results.
RALEIGH, N.C., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 4, 2025. Enact will host a conference call to review fourth quarter 2024 financial results on February 5, 2025 at 8:00 a.m. (ET). Enact's earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com/, at the time of their release to the public. Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to
Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing fourth quarter results after the market closes on February 18, 2025. A conference call will be held on February 19, 2025, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's February 19 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #5461958. To participat
Strategic Highlights Continued progress on the LTC1 multi-year rate action plan (MYRAP) with $124M of gross incremental premium approvals; approximately $30B estimated net present value achieved from in-force rate actions (IFAs) since 2012 Expanded the CareScout Quality Network to 49 states through October, covering over 75% of the aged 65-plus Census population in the United States; on track to achieve 80% to 85% coverage by year-end Executed $36M in share repurchases in the quarter; $144M executed year-to-date through October at an average price of $6.29 per share Repurchased $17M in principal of holding company debt at a discount Financial Highlights Net income2 of $85M, or $
GAAP Net Income of $181 million, or $1.15 per diluted shareAdjusted Operating Income of $182 million, or $1.16 per diluted shareReturn on Equity of 14.7% and Adjusted Operating Return on Equity of 14.8%Record Primary insurance in-force of $268 billion, a 2% increase from third quarter 2023PMIERs Sufficiency of 173% or $2,190 millionBook Value Per Share of $32.61 and Book Value Per Share excluding AOCI of $33.27Announces quarterly cash dividend of $0.185 per common share RALEIGH, N.C., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the third quarter of 2024. "Our strong third-quarter performance underscores the continued successfu
Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing third quarter results after the market closes on November 6, 2024. A conference call will be held on November 7, 2024, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's November 7 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #1689846. To participate in t
RALEIGH, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its third quarter earnings release after the market closes on November 6, 2024. Enact will host a conference call to review third quarter 2024 financial results on November 7, 2024 at 8:00 a.m. (ET). Enact's earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com/, at the time of their release to the public. Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to jo
AM Best has upgraded the Long-Term Issuer Credit Ratings (Long-Term ICRs) to "bb-" (Fair) from "b+" (Marginal) of Genworth Financial, Inc. (NYSE:GNW) and Genworth Holdings, Inc. (both domiciled in Delaware), as well their Long-Term Issue Credit Ratings (Long-Term IRs). The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed list of the Long-Term IRs.) In addition, AM Best affirmed the Financial Strength Rating (FSR) of B- (Fair) and the Long-Term ICR of "bb-" (Fair) of Genworth Life and Annuity Insurance Company (GLAIC) (Richmond, VA). The outlook of these ratings has been revised to stable from negative. Additionally, AM Best has affirmed the FSR of C++ (Margin
Strategic Highlights Continued progress on the LTC1 multi-year rate action plan (MYRAP) with $138M of gross incremental premium approvals; $29.2B estimated net present value achieved from in-force rate actions (IFAs) since 2012 CareScout continued to expand the CareScout Quality Network; now available in more than 40 states and covering greater than two-thirds of the aged 65-plus Census population in the United States Executed $36M in share repurchases in the quarter; $111M executed year-to-date through July 31, 2024, at an average price of $6.19 per share Repurchased $12M in principal of the company's subordinated notes at a discount Financial Highlights Net income2 of $7